Baader Bank Aktiengesellschaft Buys New Position in Alignment Healthcare, Inc. (NASDAQ:ALHC)

Key Points

• Baader Bank Aktiengesellschaft invested $372,000 to acquire 20,000 shares in Alignment Healthcare, marking its position as a new institutional investor in the company during the 1st quarter.
• Insider trading activity includes CEO John E. Kao selling 180,000 shares for approximately $2.41 million, representing a 10.39% decrease in his ownership, while 17.66 million shares have been sold by insiders in the last quarter.
• Analysts' ratings for Alignment Healthcare are generally positive, with a consensus of "Moderate Buy" and an average price target of $17.17, reflecting overall increased confidence in the stock's performance.

Baader Bank Aktiengesellschaft acquired a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 20,000 shares of the company's stock, valued at approximately $372,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Wellington Management Group LLP raised its holdings in Alignment Healthcare by 77.9% in the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company's stock worth $83,683,000 after acquiring an additional 3,257,630 shares during the period. T. Rowe Price Investment Management Inc. raised its holdings in Alignment Healthcare by 54.7% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company's stock worth $97,302,000 after acquiring an additional 3,059,596 shares during the period. Millennium Management LLC raised its holdings in Alignment Healthcare by 588.3% in the 4th quarter. Millennium Management LLC now owns 3,388,602 shares of the company's stock worth $38,122,000 after acquiring an additional 2,896,311 shares during the period. Point72 Asset Management L.P. bought a new position in Alignment Healthcare in the 4th quarter worth $20,087,000. Finally, Broad Bay Capital Management LP bought a new position in Alignment Healthcare in the 4th quarter worth $18,804,000. Institutional investors and hedge funds own 86.19% of the company's stock.

Insiders Place Their Bets

In other Alignment Healthcare news, insider Andreas P. Wagner sold 19,399 shares of the firm's stock in a transaction that occurred on Wednesday, June 11th. The shares were sold at an average price of $15.26, for a total value of $296,028.74. Following the transaction, the insider directly owned 204,075 shares of the company's stock, valued at approximately $3,114,184.50. This trade represents a 8.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Joseph S. Konowiecki sold 25,000 shares of the stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $16.00, for a total value of $400,000.00. Following the completion of the transaction, the director directly owned 1,152,049 shares in the company, valued at $18,432,784. The trade was a 2.12% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 17,700,753 shares of company stock valued at $269,911,757 over the last quarter. Company insiders own 7.00% of the company's stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on ALHC. Robert W. Baird boosted their price objective on shares of Alignment Healthcare from $17.00 to $22.00 and gave the stock an "outperform" rating in a report on Tuesday, April 15th. UBS Group lifted their price objective on Alignment Healthcare from $16.00 to $17.00 and gave the stock a "neutral" rating in a report on Friday, May 2nd. Stephens upgraded Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Barclays upgraded shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and increased their price objective for the company from $9.00 to $13.00 in a research note on Thursday. Finally, Stifel Nicolaus lifted their target price on shares of Alignment Healthcare from $18.00 to $23.00 and gave the company a "buy" rating in a research report on Tuesday, April 8th. Four research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $17.61.

Alignment Healthcare Price Performance

ALHC traded down $0.81 during trading on Friday, hitting $12.97. The company's stock had a trading volume of 3,566,563 shares, compared to its average volume of 3,659,441. The firm's 50 day moving average price is $13.89 and its two-hundred day moving average price is $15.32. The company has a quick ratio of 1.69, a current ratio of 1.66 and a debt-to-equity ratio of 2.29. Alignment Healthcare, Inc. has a 12 month low of $7.92 and a 12 month high of $21.06. The stock has a market capitalization of $2.57 billion, a price-to-earnings ratio of -46.32 and a beta of 1.16.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.14. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The firm had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $960.25 million. During the same quarter last year, the company posted ($0.13) EPS. The company's quarterly revenue was up 49.0% compared to the same quarter last year. Sell-side analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.